Sign Up to like & get
recommendations!
1
Published in 2017 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofx163.1078
Abstract: Abstract Background Switching to the 2-drug regimen (2DR) of DTG+RPV was proven non-inferior to continuing a suppressive PI-, INI- or NNRTI- based current antiretroviral regimen (CAR) at Week 48. This analysis evaluated the efficacy and…
read more here.
Keywords:
research;
dtg rpv;
speaker;
consulting fee ... See more keywords
Sign Up to like & get
recommendations!
4
Published in 2023 at "AIDS"
DOI: 10.1097/qad.0000000000003480
Abstract: Background: Since 2015, we prescribed dolutegravir (DTG)-based two drug regimens (DTG-2DR) for 620 people [total cohort 3133 (19.8%)]. Method: Clinic database search 1 January 15 to 31 October 21. Demographic, tolerability and HIV related data…
read more here.
Keywords:
two drug;
dtg 3tc;
dtg rpv;
dtg ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "HIV medicine"
DOI: 10.1111/hiv.13489
Abstract: INTRODUCTION Dolutegravir/rilpivirine (DTG/RPV) is an effective antiretroviral (ART) regimen endorsed by clinical trials as a switch therapy. The aim of our study was to analyse the efficacy and safety of DTG/RPV in real-world clinical practice.…
read more here.
Keywords:
world clinical;
dtg rpv;
efficacy;
clinical practice ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Antiviral Therapy"
DOI: 10.1177/13596535211073235
Abstract: Background This study compared the effectiveness and durability of DTG/RPV with commonly prescribed 3-drug regimens (3-DR) in people living with HIV (PLWH) in a real-world setting. Methods Antiretroviral therapy (ART)-experienced, virologically suppressed PLWH who initiated…
read more here.
Keywords:
virologic failure;
drug;
real world;
dtg rpv ... See more keywords